Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Montreux Equity Partners
company
About
Montreux Equity Partners is a private investment firm dedicated to building the leading healthcare companies of tomorrow.
- 1 - 10
Highlights
Details
- Industries
- Finance,Financial Services,FinTech
- Founded date
- Jan 1, 1993
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- MVC
Founded in 1993, Montreux Equity Partners is a private investment firm focused on making growth capital investments in the leading companies of tomorrow. Our portfolio companies address the most compelling domestic and global trends in health. We are currently investing out of our fifth fund.We focus on commercial stage companies that possess highly differentiated products, technologies, and services. At the time of investment, a company will typically have $5 to $50 million in revenues. Our capital fuels product expansion, new market entry, and strategic acquisitions.
Investments
Number of Investments
Number of Lead Investments
6
0
Montreux Equity Partners has made 6 investments. Their most recent investment was on
Jul 6, 2022, when Tebra raised $72M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jul 6, 2022
Tebra
|
Series B | $72M | Electronic Health Record (EHR) | — |
|
Oct 8, 2020
TigerConnect
|
Series D | $11.50M | Collaboration | — |
|
Apr 16, 2014
Epirus Biopharmaceuticals
|
Series B | $36M | Biotechnology | — |
|
Feb 20, 2014
Mindbody Business
|
Private Equity（PE） | $50M | Beauty | — |
|
Jul 1, 2012
Epirus Biopharmaceuticals
|
Series Unknown | $5M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
